{"referenced_tweets": [{"type": "replied_to", "id": "1262827568270643200"}], "possibly_sensitive": false, "reply_settings": "everyone", "in_reply_to_user_id": "822215673812119553", "created_at": "2020-05-19T19:30:12.000Z", "entities": {"annotations": [{"start": 82, "end": 84, "probability": 0.8076, "type": "Organization", "normalized_text": "FDA"}], "mentions": [{"start": 0, "end": 11, "username": "WhiteHouse", "id": "1323730225067339784"}], "urls": [{"start": 110, "end": 133, "url": "https://t.co/p1Rtsolixl", "expanded_url": "https://www.directorstalkinterviews.com/diffusion-pharmaceuticals-inc-consenus-indicates-potential-573-1-upside/412817065?amp", "display_url": "directorstalkinterviews.com/diffusion-phar\u2026"}]}, "text": "@WhiteHouse DIFFUSION PHARMACEUTICAL(DFFN)\n573% UPSIDE!!!!. Now in talks with the FDA for Covid-19 treatment!\nhttps://t.co/p1Rtsolixl", "lang": "en", "public_metrics": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}, "source": "Twitter Web App", "author_id": "3310124155", "conversation_id": "1262827568270643200", "id": "1262827918595678209", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "88", "name": "Political Body", "description": "A section of a government, like The Supreme Court"}, "entity": {"id": "871795678447456256", "name": "The White House", "description": "Conversation from and about the White House, both as a destination and as political voice"}}]}